InnovaVector is a leading European Contract Development and Manufacturing Organization (CDMO) specializing in AAV vectors for gene therapy applications. With a strong foundation built on thirty years of experience at the Telethon Institute of Genetics and Medicine (TIGEM) in Naples, Italy, InnovaVector offers comprehensive solutions for AAV vector development, production, and release. The company's state-of-the-art facility and experienced scientific team with extensive GMP background enable it to support clients from discovery to the final AAV product supply. Established in 2019, InnovaVector is situated in the subtropical Campania-region in Pozzuoli, Italy, providing a stimulating and international work environment with promising career opportunities. As a European leader in AAV vector production, InnovaVector is positioned to capitalize on the growing demand for gene therapy solutions in the biotechnology and pharmaceutical industries.
There is no investment information
No recent news or press coverage available for InnovaVector .